pharmaceutical advertising

Bringing media buying in-house is “chaotic and disruptive” – but totally worth it, according to Glenniss Richards, Bayer’s senior director of digital media.

SSPs aren’t thrilled by TTD characterizing them as “resellers”; Amazon DSP just announced a new partnership to sell Netflix inventory; and pharma brands will be subject to stricter regulations, per the FDA.

Data and tech company Fyllo announced its relaunch as an advertising partner for regulated industries, helping brands adhere to stringent state laws and publisher policies.

The odds of RFK Jr. implementing a ban on TV drug ads are slim, says our guest this week, BranchLab’s Josh Walsh. Still, pharma advertisers could face other regulatory changes over the next four years. Plus: We break down Forrester’s picks for the top 10 SSPs.

Driverless vehicles could become the next hot media channel; FDA reveals new ad guidelines for drug manufacturers; and artists come up with new ways to sabotage generative AI.

Pharma brands struggle with targeting and measurement because patient data is highly regulated. On Wednesday, Blockgraph announced a new partnership with health care data company Datavant to help improve TV measurement for pharma brands without creeping out consumers.

Mar tech company Constellation allows companies in highly regulated industries, such as auto, pharma and banking, to launch personalized and compliant assets more quickly.

Data platform Dstillery released a contextual solution with healthcare analytics company PurpleLab to help pharma advertisers target audiences without third-party cookies. The tool uses ID-less signals, such as URL, time of day of web visits and regional location, then uses that data to find patterns in online behavior that are associated with specific health conditions.